# FDA Inspection 1133164 - Booker King MD - October 22, 2020

Source: https://www.keypedia.com/records/fda_inspections/booker-king-md/559947f3-fa12-45c1-8a6d-c1e3d27fa52e
Source feed: FDA_Inspections

> FDA Inspection 1133164 for Booker King MD on October 22, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1133164
- Company Name: Booker King MD
- Inspection Date: 2020-10-22
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1133164 - 2020-10-22](https://www.keypedia.com/records/fda_inspections/booker-king-md/afb048c9-a792-4958-b750-d9bb71a5f833)

Company: https://www.keypedia.com/companies/booker-king-md/fb036f8c-26c7-4951-97f8-4ea0c310b7b2

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
